Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric thrombosis.

Carolyn Hoppe1, Alison Matsunaga

  • 1Children's Hospital and Research Center at Oakland, 747 52nd Street, Oakland, CA 94609, USA. choppe@mail.cho.org

Pediatric Clinics of North America
|February 13, 2003
PubMed
Summary

Childhood thrombosis, though rare, causes significant harm. Investigating genetic and acquired factors is crucial, as multiple risks increase thrombosis likelihood in children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disorders.

Blood advances·2026
Same author

A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease.

European journal of clinical pharmacology·2023
Same author

Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department.

British journal of haematology·2022
Same author

Vaginal Bleeding and Otorrhea in a 6-year-old Girl.

Pediatrics in review·2020
Same author

Working adeptly to diagnose and treat adult ADHD.

The Journal of family practice·2020
Same author

Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.

Hematology/oncology clinics of North America·2019

Area of Science:

  • Pediatric Hematology
  • Thrombosis Research
  • Vascular Medicine

Background:

  • Childhood thrombosis is a serious condition, leading to significant morbidity and mortality.
  • Multiple genetic and acquired factors contribute to the development of thrombosis in children.
  • Identifying underlying prothrombotic conditions is essential for effective management.

Purpose of the Study:

  • To summarize current understanding of childhood thrombosis.
  • To highlight risk factors and treatment strategies.
  • To identify areas for future research.

Main Methods:

  • Review of existing literature on pediatric thrombosis.
  • Analysis of genetic and acquired risk factors.
  • Evaluation of current anticoagulant and thrombolytic therapies.

Main Results:

  • Children with multiple genetic or acquired risk factors face a higher thrombosis risk.
  • Heparin or LMWH are used for acute treatment, with warfarin for long-term anticoagulation.
  • Recombinant tissue plasminogen activator shows safety and efficacy in pediatric thrombolysis.

Conclusions:

  • Childhood thrombosis necessitates thorough investigation of prothrombotic conditions.
  • Combined inherited and acquired defects elevate thrombosis risk.
  • Further multicenter studies are required for evidence-based treatment guidelines.

Related Experiment Videos